Navigation Links
Webcor Builders Selected as the General Contractor for First Phase of LA BioMed's New Campus Master Plan
Date:11/17/2011

LOS ANGELES, Nov. 17, 2011 /PRNewswire/ -- Webcor Builders, an award-winning general contractor specializing in a wide variety of project types, announced today it has been selected by the Los Angeles Biomedical Research Institute at Harbor–UCLA Medical Center (LA BioMed) as the general contractor of the initial phase for the creation of a 10.25-acre research park which will be located within the 72-acre Harbor-UCLA Medical Center in Torrance, California.  Webcor will work closely with ZGF Architects LLP, a national architectural, planning, and interior design firm selected by LA BioMed to develop the plans for the research facility.

LA BioMed, one of the largest independent, not-for-profit biomedical research institutes in the country, is working closely with the County of Los Angeles to implement a public-private partnership in Biotechnology.

Webcor has been selected as the general contractor for the research park due to its industry-leading technology practices and unrivaled track record, led by an accomplished management team. Webcor has built more than 50 million square feet of projects during forty years of business.  It has delivered efficient, high-performance buildings since the mid-1990s, winning several awards in sustainable "green" building.  Webcor clients include Oracle, eBay, Lucasfilm, Starwood Lodging and the California Academy of Science.

"We are delighted to announce the commencement of Phase I of our master plan and look forward to working closely with the outstanding teams at ZGF and at Webcor Builders," commented Dr. David Meyer, Chief Executive Officer of the Los Angeles Biomedical Research Institute. "ZGF's extensive experience in designing state-of-the-art research facilities, together with Webcor's exceptional reputation for quality construction and superior service, brings an innovative approach to the complex design and construction needed for cutting-edge biomedical research."

Webcor LA
'/>"/>

SOURCE Webcor Builders
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. inVentiv Health Selected to Provide Sales Operations Support for Santarus
2. Dr. Jose Ignacio Santos Selected as Simon Ramo Lecturer
3. Enantas Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of Windhovers Top 10 Infectious Disease Projects to Watch
4. Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Techs 2011 All-Stars Award
5. Center for Proteomics at the Translational Genomics Research Institute (TGen) Selected as Waters Center of Innovation
6. PharmAthene Selected for Inclusion in the Russell Global Index and Russell 3000 Index
7. NewCardio Selected to Present at 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society
8. 22 of Americas Most Promising Scientists Selected as 2011 Pew Scholars in the Biomedical Sciences
9. Dr. Frank Fisher of Stevens selected for Fulbright specialist roster
10. SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
11. Conflict of Interest Management System Selected by Henry Ford Health System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... May 4 Environmental Tectonics Corporation,s (NYSE AMEX ... Division announced today the addition of Mr. Ray ... Wyngarden will be responsible for expanding market awareness ... ETC,s other hyperbaric products in the western portion ...
... it has produced a synthetic H1N1 swine flu vaccine, Replikins PanFlu™, ... vaccine based on the same Replikins peptide technology which provided the ... was on its way. , ... London, UK (PRWEB) ...
... YORK and NASSAU, The Bahamas, May 1 Fincor ... Prospero Group (Pink Sheets: PRPG) , a leading company ... the new ACTRx Malaria and Dengue fever treatment. Fincor also ... a majority of ACTRx International Inc., which combines several natural ...
Cached Biology Technology:Environmental Tectonics Corporation Expands BioMedical Systems Division Sales Staff 2Environmental Tectonics Corporation Expands BioMedical Systems Division Sales Staff 3H1N1 Influenza "Swine Flu" Peptide Vaccine Now Available For Testing Worldwide 2Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment 2
(Date:4/15/2014)... in nanoparticle form could help reduce side effects by ... years, scientists have developed nanoparticles that deliver one or ... to design particles that can carry any more than ... have devised a new way to build such nanoparticles, ... different drugs. In a paper published in the ...
(Date:4/15/2014)... cuttlefish, squid and octopus has uncovered details of ... they may help in investigating populations of their ... 10 new parasite species− dicyemid mesozoans −, which ... and octopus). They are the very first ... , "Although dicyemid parasites have been studied ...
(Date:4/14/2014)... swallow, but if you,re over 24 years of age ... cognitive motor performance, according to a new Simon Fraser ... doctoral student, associate professor Mark Blair, Thompson,s thesis supervisor, ... student, deliver the news in a just-published PLOS ... the first social science experiments to rest on big ...
Breaking Biology News(10 mins):Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3Bizarre parasite may provide cuttlefish clues 2Study says we're over the hill at 24 2
... research has found that hurricane activity is ,clustered, rather ... ecosystems and human population. The research was carried ... Queensland Global Change Institute and School of Biological Sciences, ... Fellow) at the University of Exeter,s Exeter Climate Systems ...
... multi-disciplinary 5-year project at the University of Nevada, Reno ... $10 million in funding from the National Institutes of ... manipulate the communication between cells that causes human neurological ... of Medicine, the College of Science and the Department ...
... by researchers at The University of Texas at Austin ... a cure for Alzheimer,s disease and help answer one ... The research, led by Cockrell School of Engineering ... Assistant Professor Jon Pierce-Shimomura, aims to prevent degeneration of ...
Cached Biology News:Clustered hurricanes reduce impact on ecosystems 2$10 million grant supports biological sciences team at University of Nevada, Reno 2$10 million grant supports biological sciences team at University of Nevada, Reno 3Reversing aging 2Reversing aging 3Reversing aging 4
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
...
Mouse monoclonal to Casein Kinase 2 beta ( Abpromise for all tested applications). entrezGeneID: 1460 SwissProtID: P13862...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Biology Products: